☆ 4.6 Article

Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care

MEDICAL JOURNAL OF AUSTRALIA (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer

Pat W. Whitworth et al.

Summary: This study examines the implications of universal testing for patients with breast cancer and finds that germline genetic testing informs clinical decision-making and provides access to targeted treatments and clinical trials for all patients with breast cancer.

JAMA NETWORK OPEN (2022)

添加到收藏夹

Review Oncology

Mainstream consent programs for genetic counseling in cancer patients: A systematic review

Tahlia Scheinberg et al.

Summary: As the demand for germline genetic testing for cancer patients increases, novel methods of genetic counseling are required. Mainstream pathways, conducted by medical oncologists and nurses, have been found acceptable and feasible, with a focus on breast and ovarian cancer patients undergoing BRCA testing. Further research is needed to evaluate the mainstream pathway for men with prostate cancer.

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

A Population-Based Study of Genes Previously Implicated in Breast Cancer

Chunling Hu et al.

Summary: This study provides population-based estimates of the prevalence and risk of breast cancer associated with pathogenic variants in known cancer-predisposition genes. The results highlight the varying levels of risk associated with different genes, such as high risk for BRCA1 and BRCA2 and moderate risk for PALB2, as well as associations with specific subtypes of breast cancer for genes like RAD51C and RAD51D.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

Universal genetic testing of patients with newly diagnosed breast cancer - ready for prime time?

Dilanka L. De Silva et al.

MEDICAL JOURNAL OF AUSTRALIA (2021)

添加到收藏夹

Editorial Material Oncology

The ten genes for breast (and ovarian) cancer susceptibility

William D. Foulkes

Summary: Through two large studies, the candidacy of several questionable genes for breast and ovarian cancer risk has been resolved, resulting in a final list of ten established susceptibility genes.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Mainstream genetic testing for breast cancer patients: early experiences from the Parkville Familial Cancer Centre

Catherine Beard et al.

Summary: The mainstream clinical genetic testing program implemented in Australia allows eligible breast cancer patients to directly arrange genetic testing at oncology/surgical appointments, leading to successful uptake, notable pathogenic variant detection rate, reduced burden on FCC, and streamlined process for eligible patients. Further investigation into patient and clinician experiences is needed.

EUROPEAN JOURNAL OF HUMAN GENETICS (2021)

添加到收藏夹

Article Medicine, General & Internal

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

Andrew N. J. Tutt et al.

Summary: In patients with high-risk, HER2-negative early breast cancer and germline BRCA1 or BRCA2 pathogenic or likely pathogenic variants, adjuvant olaparib after completion of local treatment and neoadjuvant or adjuvant chemotherapy was associated with significantly longer survival free of invasive or distant disease than placebo. Olaparib had limited effects on global patient-reported quality of life.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Oncology

CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants

Tim Carver et al.

Summary: The CanRisk Tool is a next-generation web interface for the latest BOADICEA risk model, providing a user-friendly platform for multifactorial breast and ovarian cancer risk predictions. With over 3,100 account registrations and 98,000 risk calculations within the first 9 months of launch, it has shown significant impact in boosting accessibility for healthcare professionals and researchers.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

添加到收藏夹

Article Medicine, General & Internal

Breast cancer

Nadia Harbeck et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

添加到收藏夹

Article Oncology

A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer

Li Sun et al.

JAMA ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?

Peter D. Beitsch et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer

Zoe Kemp et al.

JAMA NETWORK OPEN (2019)

添加到收藏夹

Article Oncology

Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark

Shan Yang et al.

ANNALS OF SURGICAL ONCOLOGY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history

Bettina Meiser et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2018)

添加到收藏夹

Article Medicine, General & Internal

Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing

Jacqueline Mersch et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

添加到收藏夹

Editorial Material Medicine, General & Internal

Medicare-funded cancer genetic tests: a note of caution Clinicians need appropriate education and support in keeping pace with the genomics revolution

Judy Kirk et al.

MEDICAL JOURNAL OF AUSTRALIA (2018)

添加到收藏夹

Article Genetics & Heredity

Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial

Veronica F. Quinn et al.

GENETICS IN MEDICINE (2017)

添加到收藏夹

Article Genetics & Heredity

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

Sue Richards et al.

GENETICS IN MEDICINE (2015)

添加到收藏夹

Article Oncology

Health professionals' evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer

Kirsten F. L. Douma et al.

FAMILIAL CANCER (2015)

添加到收藏夹

Article Oncology

The Concerns About Recurrence Questionnaire: validation of a brief measure of fear of cancer recurrence amongst Danish and Australian breast cancer survivors

Belinda Thewes et al.

JOURNAL OF CANCER SURVIVORSHIP (2015)

添加到收藏夹

Article Computer Science, Interdisciplinary Applications

Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support

Paul A. Harris et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2009)

添加到收藏夹

Article Genetics & Heredity

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation:: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics

A. C. Antoniou et al.

JOURNAL OF MEDICAL GENETICS (2008)

添加到收藏夹

Article Health Care Sciences & Services

Validation of a decision regret scale

JC Brehaut et al.

MEDICAL DECISION MAKING (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.